 Receptors, Complement 3d
"Receptors, Complement 3d" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Molecular sites on or in B-lymphocytes, follicular dendritic cells, lymphoid cells, and epithelial cells that recognize and combine with COMPLEMENT C3D. Human complement receptor 2 (CR2) serves as a receptor for both C3dg and the gp350/220 glycoprotein of HERPESVIRUS 4, HUMAN, and binds the monoclonal antibody OKB7, which blocks binding of both ligands to the receptor.
| Descriptor ID |
D017464
|
| MeSH Number(s) |
D12.776.543.750.705.833.610 D12.776.543.750.830.250
|
| Concept/Terms |
Receptors, Complement 3d- Receptors, Complement 3d
- Herpesvirus 4 Receptors, Human
- Epstein-Barr Virus Receptor
- Epstein Barr Virus Receptor
- Receptor, Epstein-Barr Virus
- Virus Receptor, Epstein-Barr
- Receptors, Epstein-Barr Virus
- Receptors, Epstein Barr Virus
- Virus Receptors, Epstein-Barr
- Epstein-Barr Virus Receptors
- Epstein Barr Virus Receptors
- C3d Receptors
- Receptors, C3d
- CD21 Antigen
- Antigen, CD21
- Antigens, CD21
- CD21 Antigens
- CR2 Receptors
- Receptors, CR2
- CD 21 Antigens
- Antigens, CD 21
- Complement Receptor 2
- Receptor 2, Complement
- Complement Receptors 2
- Receptors 2, Complement
- Complement 3d Receptor
- Receptor, Complement 3d
- Complement 3d Receptors
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Complement 3d".
Below are MeSH descriptors whose meaning is more specific than "Receptors, Complement 3d".
This graph shows the total number of publications written about "Receptors, Complement 3d" by people in this website by year, and whether "Receptors, Complement 3d" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 2 | 0 | 2 | | 1995 | 3 | 0 | 3 | | 1996 | 1 | 0 | 1 | | 1997 | 4 | 1 | 5 | | 1998 | 4 | 0 | 4 | | 2000 | 1 | 0 | 1 | | 2001 | 6 | 1 | 7 | | 2002 | 2 | 0 | 2 | | 2003 | 1 | 0 | 1 | | 2004 | 3 | 1 | 4 | | 2005 | 6 | 1 | 7 | | 2006 | 3 | 1 | 4 | | 2007 | 6 | 0 | 6 | | 2008 | 3 | 0 | 3 | | 2009 | 5 | 1 | 6 | | 2010 | 2 | 0 | 2 | | 2011 | 2 | 1 | 3 | | 2012 | 4 | 1 | 5 | | 2013 | 1 | 0 | 1 | | 2014 | 1 | 0 | 1 | | 2015 | 3 | 0 | 3 | | 2017 | 0 | 1 | 1 | | 2018 | 1 | 0 | 1 | | 2019 | 0 | 1 | 1 | | 2020 | 0 | 1 | 1 | | 2022 | 0 | 1 | 1 | | 2023 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Receptors, Complement 3d" by people in Profiles.
-
Li Y, Jacques S, Gaikwad H, Wang G, Banda NK, Holers VM, Scheinman RI, Tomlinson S, Moghimi SM, Simberg D. Inhibition of acute complement responses towards bolus-injected nanoparticles using targeted short-circulating regulatory proteins. Nat Nanotechnol. 2024 Feb; 19(2):246-254.
-
Schriek P, Ching AC, Moily NS, Moffat J, Beattie L, Steiner TM, Hosking LM, Thurman JM, Holers VM, Ishido S, Lahoud MH, Caminschi I, Heath WR, Mintern JD, Villadangos JA. Marginal zone B cells acquire dendritic cell functions by trogocytosis. Science. 2022 02 11; 375(6581):eabf7470.
-
Phalke S, Aviszus K, Rubtsova K, Rubtsov A, Barkes B, Powers L, Warner B, Crooks JL, Kappler JW, Fern?ndez-P?rez ER, Maier LA, Hamzeh N, Marrack P. Age-associated B Cells Appear in Patients with Granulomatous Lung Diseases. Am J Respir Crit Care Med. 2020 10 01; 202(7):1013-1023.
-
Smith NA, Coleman CB, Gewurz BE, Rochford R. CD21 (Complement Receptor 2) Is the Receptor for Epstein-Barr Virus Entry into T Cells. J Virol. 2020 05 18; 94(11).
-
Mensah KA, Chen JW, Schickel JN, Isnardi I, Yamakawa N, Vega-Loza A, Anolik JH, Gatti RA, Gelfand EW, Montgomery RR, Horowitz MC, Craft JE, Meffre E. Impaired ATM activation in B cells is associated with bone resorption in rheumatoid arthritis. Sci Transl Med. 2019 11 20; 11(519).
-
Greaves SA, Peterson JN, Strauch P, Torres RM, Pelanda R. Active PI3K abrogates central tolerance in high-avidity autoreactive B cells. J Exp Med. 2019 05 06; 216(5):1135-1153.
-
Fridkis-Hareli M, Storek M, Or E, Altman R, Katti S, Sun F, Peng T, Hunter J, Johnson K, Wang Y, Lundberg AS, Mehta G, Banda NK, Michael Holers V. The human complement receptor type 2 (CR2)/CR1 fusion protein TT32, a novel targeted inhibitor of the classical and alternative pathway C3 convertases, prevents arthritis in active immunization and passive transfer mouse models. Mol Immunol. 2019 01; 105:150-164.
-
Wohlford EM, Baresel PC, Wilmore JR, Mortelliti AJ, Coleman CB, Rochford R. Changes in Tonsil B Cell Phenotypes and EBV Receptor Expression in Children Under 5-Years-Old. Cytometry B Clin Cytom. 2018 03; 94(2):291-301.
-
He YG, Pappworth IY, Rossbach A, Paulin J, Mavimba T, Hayes C, Kulik L, Holers VM, Knight AM, Marchbank KJ. A novel C3d-containing oligomeric vaccine provides insight into the viability of testing human C3d-based vaccines in mice. Immunobiology. 2018 01; 223(1):125-134.
-
Hannan JP. The Structure-Function Relationships of Complement Receptor Type 2 (CR2; CD21). Curr Protein Pept Sci. 2016; 17(5):463-87.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|